01/19/2023 - Dr. Gargee Mulye SBRT vs Vivek Anand HDR - India GU Brachy SBRT
Chartrounds India - SBRT
•
1h 7m
brachytherapy, prostate cancer, monotherapy, EBRT, hypofractionation, SBRT, side effects, QOL, quality of life, IPSS, meta-analysis, HDR, LDR, urinary adverse events, ASCENDE-RT, DE-EBRT, LDR-PB, FLAME, toxicity profile, IMRT, SHORT, Gy, HR prostate cancer, risk groups, cell survival, radiation dose, dose distribution, iodine 125 suppliers, seeds, HDR brachytherapy flow chart, dosimetry, intermediate risk, BT Boost, randomised trials, long term outcomes, MRL, guided LINACs, Afterloader
Up Next in Chartrounds India - SBRT
-
04/13/2023 - Dr. Vineeta Goel - Radia...
mutation positive NSCLC, CNS metastases, immunogenic tumour, tumor, TKI, IO, chemotherapy, radiation therapy, tumor biology, non-small cell lung cancer, brain metastases, SRS, radiation necrosis, lung molecular graded prognostic assessment, GPA, adenocarcinoma, ALK mutated NSCLC, ALK rearrangemen...
-
07/27/2023 - Dr. Indranil Mallick - R...
-
India SBRT Lung Sayan Paul August 10 ...
